1ELIT L,OLIVEr TKm,COVENS A,ot al.Intraperitoneal chemotherapy in the first-line treatment of women with stageⅢepithelial ovarian cancer:a systematic review with metaanalyses[J].Cancer,2007,109:692.
2TSUBURAYA A,SAKAMOTO J,OTRITA S,et al.A randomized phase Ⅲ trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluorogpyrimidine.and UFT versus S1 for T3/T4 gastric carcinoma:the stomach cancer adjuvant Multi-institu-tional Trial Group(Sumit)Trial[J].Jpn J Clin Oncol,2005,35:672.
3MARKMAN M,FRANCIS P,ROWINSKY E,et al Intraperitoneal TAXOL(paelitaxel)in the management of ovarian cancer[J].Ann Oncol,1995,5:55.
4MARKMAN M,FRANCIS P,ROWINSKY E,et al.Intraperitoneal paelitaxei:a possible role in the managenment of ovarian cancer[J].Semin Oncol,1995,22:84.
5MARKMAN M,ROWINSKY E,SCHNEIDER J,et al Phase Ⅰ trial of intraperitioneal taxol:a gynecologic oncology Group study[J].J Clin Oncol,1992,10:1485.
6FRANCIS P,ROWINDKY E,SCHNEIDER J,et al.Phase Ⅰ feasibility and pharmacologic study of weekly intraperitoneal paelitaxel:a Gynecologic Ontology Group pilot study[J].J Clin Oncol,1995,13:2961.
7SHINOHARA H,OKAMOTO S,NISHITAI R,et al.A phase Ⅰ study of intraperitoneal plus intravenous paclitaxel against gastric cancer with peritoneal dissemination(HGCG 0301)[J].Gan To Kagaku Ryoho,2006,33:2027.
9MARKMAN M,BRADY MF,SPIRTOS NM,et al PhaseⅡtrial of intraperitoneal paclitaxel in carcinoma of the ovary,tube,and peritoneum:a gynecologic ontology group study[J].Clin Oneol,1998,16:2620.
10ANDREAS DU B,HANS-JOACHIM L,WERNER M,et al.Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer[J].Semin Oncol,1996,24:28.
7Ohta Y, Shimizu Y, Matssumoto I, et al. Management of malignant pleural effusion by multimodality treatment including the use of paclitaxel administered by 24-hour intrathoracic infusion for pa- tients with carcinomatous pleuritis [ J]. Exp Clin Cancer Res, 2006,25( 1 ) :15 - 19.
8Perng RP, Chen YM, Wu MF, et al. Phase Ⅱ trial of intrapleural paclitaxel injection for nonsmall-cell lung cancer patients with malignant pleural effusions [ J ]. Respir Med, 1998,92 ( 3 ) : 473 - 479.
9Inan I, Sousa S, Myers P, et al. Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter port system[ J]. World Journal of Surgical Oncology,2008,6 (1) :85 -91.
10Warren WH, Kalimi R, Khodadadian LM, et al. Management of malignant pleural effusions using the Pleur(x) catheter[ J ]. Ann Thorac Surg ,2008,85 ( 3 ) : 1049 - 1055.
